Komori
Nichiban (4218) · InitiativeAdvanced

Development of Overseas Sales Channels Starting with the Bangkok Representative Office

First written in FY2016. 10 of 20 entries say "Restated". Latest entry: FY2025-H1.

20entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2019-Q3RestatedFY2022-Q22016: 320162017: 420172018: 420182019: 220192020: 320202021: 320212022: 020222023: 020232024: 12024
Same theme, other companies
Strengthening overseas customer acquisition, sales networks and business expansion, with a focus on AsiaA theme 324 companies write about · 3 as a headwind · 353 as a tailwind

The whole theme swung hardest in 2020: 18 of 128 companies on the "Worse" side.

96 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 181 companies compared. The sentences above are computed from all 181.Comparing 200 of the theme's 358 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1AdvancedAnnual report

    「Following the overseas bases in Thailand and Germany, we began actively pursuing initiatives such as launching research into the Chinese market from the Shanghai representative office, which opened in July」

    In addition to the overseas bases in Thailand and Germany, research into the Chinese market began from the Shanghai representative office opened in July.
  2. FY2022-Q2RestatedAnnual report

    「In Asia and Europe, our priority regions, we conducted sales activities focused on building sales channels and developing products, including expanding applications and developing markets for “PanfixTM Cellulose Tape” and Japanese paper masking tape for painting」

    The company continues to build sales channels, develop markets and develop products through overseas bases, including those in Thailand and Germany.
  3. FY2021AdvancedAnnual report

    「NICHIBAN EUROPE GmbH was established in Düsseldorf, Germany, and began sales activities more closely aligned with the local market.」

    Following the establishment of the German sales subsidiary, locally focused sales activities began in Europe.
  4. FY2021-Q3AdvancedAnnual report

    「During the third quarter consolidated accounting period, NICHIBAN EUROPE GmbH was established in Düsseldorf, Germany, to strengthen business operations and expand sales throughout Europe.」

    The initiative progressed from the research and preparation stage at the German representative office to the establishment of a European sales subsidiary.
  5. FY2021-Q2AdvancedAnnual report

    「We are proceeding with the establishment of a sales base in Germany to strengthen business operations and expand sales throughout Europe.」

    The initiative has progressed from information gathering and market research at the Düsseldorf representative office in Germany to establishing a sales base aimed at expanding operations and sales throughout Europe.
  6. FY2021-Q1RestatedAnnual report

    「At the Düsseldorf representative office in Germany, we conducted information gathering and market research to promote the expansion of the sales business and growth strategy in Europe. At NICHIBAN (THAILAND) CO., LTD., the sales subsidiary in Bangkok, Thailand, we worked to expand sales of the advanced first-aid bandage “CareLeaverTM” series in the ASEAN region, where even stronger demand is expected.」

    The company continues European market research at the Düsseldorf representative office and CareLeaver sales expansion in the ASEAN region through the Thai sales subsidiary.
  7. FY2020-Q3RestatedAnnual report

    「Through NICHIBAN (THAILAND) CO., LTD., our sales subsidiary in Bangkok, Thailand, we will work to expand sales of the CareleavesTM series of high-performance wound dressings in the ASEAN region, where significantly greater demand is expected.」

    The company continues to expand CareLeaver sales in the ASEAN region through the Thai sales subsidiary.
  8. FY2020-Q2AdvancedAnnual report

    「Through NICHIBAN (THAILAND) CO., LTD., our sales subsidiary in Bangkok, Thailand, we will work to expand sales of the CareleavesTM series of high-performance wound dressings in the ASEAN region, where significantly greater demand is expected.」

    The Bangkok sales subsidiary’s activities have expanded from sales centered on Thailand to expanding CareLeaver sales throughout the ASEAN region.
  9. FY2019-Q3RestatedAnnual report

    「In Asia, a priority region, we are promoting sales activities closely aligned with the local market through NICHIBAN (THAILAND) CO., LTD., the sales subsidiary in Bangkok, Thailand, and working to expand sales.」

    The Thai sales subsidiary continues to conduct sales activities closely aligned with the local market and expand sales.
  10. FY2019-Q2RestatedAnnual report

    「We are promoting sales activities closely aligned with the local market through NICHIBAN (THAILAND) CO., LTD., a sales subsidiary established in Bangkok, Thailand, in the previous consolidated fiscal year, and working to expand sales.」

    The company continues locally focused sales activities and sales expansion through the Thai sales subsidiary.
  11. FY2019-Q1RestatedAnnual report

    「We are promoting sales activities closely aligned with the local market through NICHIBAN (THAILAND) CO., LTD., a sales subsidiary established in Bangkok, Thailand, in the previous consolidated fiscal year, and working to expand sales.」

    The Thai sales subsidiary continues to conduct sales activities closely aligned with the local market and expand sales.
  12. FY2018AdvancedAnnual report

    「We have also established distribution channels with local business partners and aim to expand sales of the advanced first-aid bandage “CareLeaverTM” in Asian markets, where stronger demand is expected」

    The Thai sales subsidiary’s sales-channel development has progressed to establishing distribution channels with local business partners and expanding sales of key products.
  13. FY2018-Q3AdvancedAnnual report

    「During the second quarter consolidated accounting period, NICHIBAN (THAILAND) CO., LTD. was newly established in Bangkok, Thailand, and included in the scope of consolidation.」

    The company explicitly stated that NICHIBAN (THAILAND) CO., LTD., its sales subsidiary in Bangkok, Thailand, was included in the scope of consolidation, indicating that the overseas sales base had been integrated into group operations.
  14. FY2018-Q2AdvancedAnnual report

    「During the second quarter consolidated accounting period, sales activities were launched through NICHIBAN (THAILAND) CO., LTD., a sales subsidiary established in Bangkok, Thailand,」

    The initiative progressed from conventional marketing activities and sales-channel development to the launch of actual sales activities by the Thai sales subsidiary.
  15. FY2018-Q1RestatedAnnual report

    「In the overseas business, the Company continues marketing activities in each country and is developing products to meet overseas demand. It is also building sales channels for Medical Business products, such as the high-performance first-aid adhesive bandage Careleaves™ and the Sesabric™ series of hemostatic products, and Tape Business products, such as Panfix™ Cellulose Tape and Japanese paper masking tape for painting.」

    The company continues to build overseas sales channels, conduct marketing in each country, and develop products tailored to demand.
  16. FY2017AdvancedAnnual report

    「At a meeting of the Board of Directors held on 8 May 2017, the company resolved to establish a sales subsidiary in Bangkok, Thailand, as follows: capital of THB 10 million (approximately ¥32 million), scheduled establishment date: August 2017.」

    The initiative progressed from activities based at the Bangkok representative office to the planned establishment of a sales subsidiary in August 2017.
  17. FY2017-Q3RestatedAnnual report

    「We continued marketing activities in each country, pursued product development tailored to overseas demand, and exhibited at trade fairs, business-matching events and other venues to build sales channels and expand sales.」

    The company continues to build sales channels through overseas marketing, demand-driven product development, and trade fairs and business-matching events.
  18. FY2017-Q2RestatedAnnual report

    「We continued marketing activities in each country, pursued product development tailored to overseas demand, and exhibited at trade fairs, business-matching events and other venues to build sales channels and expand sales.」

    The company continues to build sales channels through overseas marketing, demand-driven product development, and trade fairs and business-matching events.
  19. FY2017-Q1RestatedAnnual report

    「Using the representative office in Bangkok, Thailand, as a base, we continued marketing activities in each country, pursued product development tailored to overseas demand, and exhibited at trade fairs, business-matching events and other venues in each country to build sales channels and expand sales.」

    The company continues to build sales channels through its existing Bangkok base, trade fairs and business-matching events, and product development tailored to local demand.
  20. FY2016First statedAnnual report

    「Using the Bangkok representative office in Thailand, which was opened in the previous consolidated fiscal year, as a base, we continued marketing activities in Asian markets, mainly for medical products, pursued product development tailored to demand in each country, and actively participated in overseas trade fairs and other events to build sales channels.」

    Sales channels are being built by combining the Bangkok base, products tailored to local demand, and overseas trade fairs.
Moved together

"International Expansion of Medical Products in Asia and Europe" moved the same way as this thread, in the same document, in 8 of its 20 moves.

876543★123456
  1. ★This thread
  2. 1International Expansion of Medical Products in Asia and Europe8×
  3. 2Strengthening efforts to raise product brand awareness and promote sales7×
  4. 3Creation of Major Development Products6×
  5. 4Cost Reduction, Environmental Initiatives and Crisis Management through Large-Scale Capital Investment5×
  6. 5Maintaining the Brand and Strengthening the Earnings Structure4×
  7. 6Strengthening Research into Adhesives, Transdermal Absorption and Environmental Technologies3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Nichiban's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.